Back to Journals » Drug Design, Development and Therapy » Volume 14

Metabolic Stability Assessment of New PARP Inhibitor Talazoparib Using Validated LC–MS/MS Methodology: In silico Metabolic Vulnerability and Toxicity Studies

Total article views   HTML views PDF downloads Totals
7,781 Dovepress* 6,916+ 1,038 7,954
PubMed Central* 865 195 1,060
Totals 7,781 1,233 9,014
*Since 25 February 2020
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar